Expression of the carbohydrate tumor marker Sialyl Lewis a (Ca19-9) in squamous cell carcinoma of the larynx

Anticancer Research

Volumn 30, Issue 5, 2010, Pages 1849-1853

  Wiest, Irmi ^a   Alexiou, Christoph ^b   Mayr, Doris ^a   Schulze, Sandra ^a   Kuhn, Christina ^a   Kunze, Susanne ^a   Büttner, Mareike ^c   Betz, Peter ^c   Jeschke, Udo ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Department of Oto rhino laryngology Head and Neck Surgery   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

CA19 9; Larynx carcinoma; Phlogistic tissue; Sialyl Lewis a; Squamous cell carcinoma

Indexed keywords

CA 19-9 ANTIGEN; SIALYL LEWIS A ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; BREAST CANCER; CANCER TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UPREGULATION;

ANTIGENS, CD15; CA-19-9 ANTIGEN; CARBOHYDRATES; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LARYNGEAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77954619088     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Capelli M et al: Neuroendocrine carcinomas of the upper airways: a small case series with histopathological considerations. Tumori 93: 499-503, 2007. (Pubitemid 350203927)
2. Gallegos-Hernandez JF et al: Human papillomavirus: association with head and neck cancer. Cir Cir 75: 151-5, 2007.
3. Esser D et al: Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings. Laryngorhinootologie 79: 478-82, 2000.
4. Lehnerdt GFet al: The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynx. Laryngoscope 118: 2172-6, 2008.
5. Matthias C et al: Keratin 8 expression in head and neck epithelia. BMC Cancer 8: 267, 2008.
6. Sheth AN, Moore RD and Gebo KA: Provision of general and HIV-specific health maintenance in middle aged and older patients in an urban HIV clinic. AIDS Patient Care STDS 20: 318-325, 2006.
7. Seo PH, Pieper CF and Cohen HJ: Effects of cancer history and comorbid conditions on mortality and healthcare use among older cancer survivors. Cancer 101: 2276-2284, 2004.
8. Llewellyn CD et al: Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. Oral Oncol 39: 106-114, 2003.
9. Grunbaum JA et al: Youth risk behavior surveillance - United States, 2001. MMWR Surveill Summ 57: 1-62, 2002.
10. Dunne JR et al: Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 102: 237-244, 2002.
11. Lopez-de-Munain J et al: Prevention in routine general practice: activity patterns and potential promoting factors. Prev Med 32: 13-22, 2001.
12. Vlock DR: Immunobiologic aspects of head and neck cancer. Clinical and laboratory correlates. Hematol Oncol Clin North Am 5: 797-820, 1991.
13. Wynder EL et al: Comparative epidemiology of cancer between the United States and Japan. A second look. Cancer 67: 746-763, 1991.
14. Raymond L and Bouchardy C: Risk factors of cancer of the pancreas from analytic epidemiologic studies. Bull Cancer 77: 47-68, 1990.
15. Sales J et al: Alcohol consumption, cigarette sales and mortality in the United Kingdom: an analysis of the period 1970-1985. Drug Alcohol Depend 24: 155-160, 1989.
16. Zapater E et al: Prognostic factors in supraglottic laryngeal cancer: a review of 74 cases. Acta Otorrinolaringol Esp 57: 120-28, 2000. (Pubitemid 30265762)
17. Lin HW and Bhattacharyya N: Staging and survival analysis for nonsquamous cell carcinomas of the larynx. Laryngoscope, 118: 1003-1013, 2008.
18. Holland JM et al: Second malignancies in early stage laryngeal carcinoma patients treated with radiotherapy. J Laryngol Otol 116: 190-193, 2002.
19. Spector JG et al: Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 111: 1079-1087, 2001.
20. Ferri T et al: The value of CT scans in improving laryngoscopy in patients with laryngeal cancer. Eur Arch Otorhinolaryngol 256: 395-399, 1999. (Pubitemid 29472188)
21. Ji W, Guan C and Pan Z: Analysis of curative effects on laryngeal carcinoma patients in the northeast region of China. Acta Otolaryngol 128: 574-577, 2008.
22. Ferlito A, Silver CE and Rinaldo A: Selective neck dissection (IIA, III): a rational replacement for complete functional neck dissection in patients with NO supraglottic and glottic squamous carcinoma. Laryngoscope 118: 676-679, 2008. (Pubitemid 351496753)
23. Eckel H.E et al: [Surgical treatment options in laryngeal and hypopharyngeal cancer]. Wien Med Wochenschr, 158: 255-63, 2008.
24. Zhang DG et al: Surgical management and preservation of laryngeal function for senile patients with advanced laryngeal carcinoma. Zhonghua Zhong Liu Za Zhi 29: 379-381, 2007.
25. Nagatani G et al: Clinical study of early laryngeal cancer. Nippon Jibiinkoka Gakkai Kaiho 110: 447-452, 2007.
26. Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (1RS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8: 138-140, 1987.
27. Wiest I et al: Expression of the carbohydrate tumour marker SLeX, SLeA (CA19-9), LeY and Thomsen-Friedenreich (TF) antigen on normal squamous epithelial tissue of the penis and vagina. Anticancer Res 27: 1981-1988, 2007.
28. Minas V et al: Expression of the blood-group-related antigens Sialyl Lewis a, Sialyl Lewis x and Lewis y in term placentas of normal, preeclampsia, IUGR- and HELLP-complicated pregnancies. Histochem Cell Biol 128: 55-63, 2007. (Pubitemid 46986250)
29. Monzavi-Karbassi B et al: Deficiency in surface expression of E-selectin ligand promotes lung colonization in a mouse model of breast cancer. Int J Cancer 117: 398-408, 2005. (Pubitemid 41429563)
30. Kannagi R et al: Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 95: 377-384, 2004. (Pubitemid 38832679)
31. Kannagi R: Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited. Glycoconj J 20: 353-364, 2004.
32. Imai Y, Lasky LA and Rosen SD: Further characterization of the interaction between L-selectin and its endothelial ligands. Glycobiology 2: 373-381, 1992.
33. Green PJ et al: High affinity binding of the leucocyte adhesion molecule L-selectin to 3′-sulphated-Le(a) and -Le(x) oligosaccharides and the predominance of sulphate in this interaction demonstrated by binding studies with a series of lipid-linked oligosaccharides. Biochem Biophys Res Commun 188: 244-251, 1992.
34. Foxall C et al: The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide. J Cell Biol 117: 895-902, 1992.
35. Erbe DV et al: Identification of an E-selectin region critical for carbohydrate recognition and cell adhesion. J Cell Biol 119: 215-227, 1992.
36. Phillips ML et al: ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 250: 1130-1132, 1990.
37. Hayashi M et al: A convenient and efficient synthesis of SLeX analogs. J Org Chem 61: 2938-2945, 1996. (Pubitemid 26170198)
38. Stahn R et al: Multivalent sialyl Lewis x ligands of definite structures as inhibitors of E-selectin mediated cell adhesion. Glycobiology 8: 311-319, 1998. (Pubitemid 28186630)
39. Stahn R et al: Human chorionic gonadotropin (hCG) as inhibitior of E-selectin-mediated cell adhesion. Anticancer Res 25: 1811-1816, 2005.
40. Jeschke U et al: Human amniotic fluid glycoproteins expressing sialyl Lewis carbohydrate antigens stimulate progesterone production in human trophoblasts in vitro. Gynecol Obstet Invest 58: 207-211, 2004. (Pubitemid 39482658)
41. Jeschke U et al: N-Glycans of human amniotic fluid transferrin stimulate progesterone production in human first trimester trophoblast cells in vitro. J Perinat Med 32: 248-253, 2004. (Pubitemid 38737531)
42. Lowe JB: Selectin ligands, leukocyte trafficking, and fucosyltransferase genes. Kidney Int 51: 1418-1426, 1997.
43. Kuijpers TW: Terminal glycosyltransferase activity: a selective role in cell adhesion. Blood 81: 873-882, 1993.
44. Shur BD: Embryonal carcinoma cell adhesion: the role of surface galactosyltransferase and its 90K lactosaminoglycan substrate. Dev Biol 99: 360-372, 1983.
45. Wakabayashi M et al: Lewis Y antigen expression in hepatocellular carcinoma. An immunohistochemical study. Cancer 75: 2827-2835, 1995.